Government signs deals with BioNTech/Pfizer and Valneva for COVID vaccines

Pharma Times

20 July 2020 - The Government has signed new deals with BioNTech/Pfizer and Valneva for access to 90 million doses of experimental COVID-19 vaccines.

Through its partnership with Valneva, for 60 million doses of its inactivated whole virus vaccine VLA2001, the government is expected to contribute to UK clinical studies costs and is negotiating funding to expand the firm's Scottish facility.

This increased manufacturing capacity could potentially supply up to 100 million vaccine doses to the UK and internationally, and will create high-skilled jobs in the local area.

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Vaccine , Supply , COVID-19